Literature DB >> 14692914

Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy.

Martin J Gallagher, Lawrence N Eisenman, Kelly M Brown, Ebru Erbayat-Altay, Hrvoje Hecimovic, A James Fessler, Hrayr P Attarian, Frank G Gilliam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14692914     DOI： 10.1111/j.0013-9580.2004.39503.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  2 in total

1.  Angelman syndrome: need for further illumination in the theater of the happy puppet.

Authors:  Raman Sankar
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 2.  Benefit-risk assessment of levetiracetam in the treatment of partial seizures.

Authors:  Bassel Abou-Khalil
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.